Impact of the basal metabolic ratio in predicting early deaths after allogeneic stem cell transplantation

American Journal of Hematology

Volumn 84, Issue 9, 2009, Pages 608-611

  Nishiwaki, Satoshi ^a   Miyamura, Koichi ^a   Seto, Aika ^a   Watanabe, Keisuke ^a   Yanagisawa, Mayumi ^a   Imahashi, Nobuhiko ^a   Shimba, Makoto ^a   Yasuda, Takahiko ^a   Kuwatsuka, Yachiyo ^a   Oba, Taku ^a   Terakura, Seitaro ^a   Kodera, Yoshihisa ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BASAL METABOLIC RATE; BODY MASS; BODY WEIGHT; DEATH; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BASAL METABOLISM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 69549105601     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21486     Document Type: Article

References (30)

1. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 2005;106:2912-2919. (Pubitemid 41510773)
2. Bacigalupo A, Sormani MP, Lamparelli T, et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004;89:1238-1247. (Pubitemid 39390450)
3. Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 1998;16:3796-3802.
4. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998; 339:1177-1185. (Pubitemid 28482126)
5. Cahn JY, Labopin M, Schattenberg A, et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 1997;11:416-419. (Pubitemid 27120992)
6. Ringden O, Horowitz MM, Gale RP, et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 1993;270:57-60. (Pubitemid 23202651)
7. Li SC, Schmiedek F. Age is not necessarily aging: Another step towards understanding the "clocks" that time aging. Gerontology 2002;48:5-12.
8. Olde Rikkert MG. Visual estimation of biological age of elderly subjects: Good interrater agreement. Gerontology 1999;45:165-167.
9. Borkan GA, Bachman SS, Norris AH. Comparison of visually estimated age with physiologically predicted age as indicators of rates of aging. Soc Sci Med 1982;16:197-204.
10. Wang Z, Heshka S, Heymsfield SB, et al. A cellular-level approach to predicting resting energy expenditure across the adult years. Am J Clin Nutr 2005; 81:799-806. (Pubitemid 41724986)
11. Frisard MI, Broussard A, Davies SS, et al. Aging, resting metabolic rate, and oxidative damage: Results from the Louisiana healthy aging study. J Gerontol A Biol Sci Med Sci 2007;62:752-759. (Pubitemid 350143607)
12. Poehlman ET. Energy expenditure and requirements in aging humans. J Nutr 1992;122:2057-2065.
13. Alfonzo-Gonzalez G, Doucet E, Bouchard C, Tremblay A. Greater than predicted decrease in resting energy expenditure with age: Cross-sectional and longitudinal evidence. Eur J Clin Nutr 2006;60:18-24. (Pubitemid 43731070)
14. Piers LS, Soares MJ, McCormack LM, O'Dea K. Is there evidence for an age-related reduction in metabolic rate? J Appl Physiol 1998;85:2196-2204.
15. Tisdale MJ. Cancer cachexia: Metabolic alterations and clinical manifestations. Nutrition 1997;13:1-7. (Pubitemid 27098605)
16. Evers BM, Townsend CM Jr, Thompson JC. Organ physiology of aging. Surg Clin North Am 1994;74:23-39.
17. Lindmark L, Bennegard K, Eden E, et al. Resting energy expenditure in malnourished patients with and without cancer. Gastroenterology 1984;87:402-408. (Pubitemid 14092404)
18. Torelli GF, Cascino A, Muscaritoli M, et al. Energy metabolism in cancer patients. Minerva Gastroenterol Dietol 1997;43:183-188.
19. Gallagher D, Belmonte D, Deurenberg P, et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol 1998;275:E249-E258. (Pubitemid 28391803)
20. Shapira MY, Tsirigotis P, Resnick IB, et al. Allogeneic hematopoietic stem cell transplantation in the elderly. Crit Rev Oncol Hematol 2007;64:49-63. (Pubitemid 47364829)
21. Tsirigotis P, Bitan RO, Resnick IB, et al. A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients. Haematologica 2006;91:852-855. (Pubitemid 44014560)
22. Valcarcel D, Martino R, Sureda A, et al. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. Eur J Haematol 2005;74:144-151. (Pubitemid 40175319)
23. Deeg HJ, Seidel K, Bruemmer B, Pepe MS, Appelbaum FR. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995;15:461-468.
24. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918;4:370-373.
25. Varterasian M, Fingert H, Agin M, Meyer M. Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer. Clin Cancer Res 2004;10:5967-5968. (Pubitemid 39180979)
26. Ostrowski S, Grzywa-Celinska A, Mieczkowska J, et al. Pulmonary function between 40 and 80 years of age. J Physiol Pharmacol 2005;56(Suppl 4): 127-133.
27. Tokunaga K, Matsuzawa Y, Kotani K, et al. Ideal body weight estimated from the body mass index with the lowest morbidity. Int J Obes 1991;15:1-5. (Pubitemid 20315115)
28. Welle S, Nair KS. Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 1990;258:E990-E998. (Pubitemid 20210382)
29. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999;18:695-706. (Pubitemid 29126745)
30. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.